Kristine Ball
2018
In 2018, Kristine Ball earned a total compensation of $1.3M as Senior Vice President, Corporate Strategy and Chief Financial Officer at VYNE Therapeutics, a 27% increase compared to previous year.
Compensation breakdown
| Bonus | $160,000 |
|---|---|
| Option Awards | $705,478 |
| Salary | $400,000 |
| Total | $1,265,478 |
Ball received $705.5K in option awards, accounting for 56% of the total pay in 2018.
Ball also received $160K in bonus and $400K in salary.
Rankings
In 2018, Kristine Ball's compensation ranked 8,022nd out of 14,244 executives tracked by ExecPay. In other words, Ball earned more than 43.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,022 out of 14,244 | 44th |
Division Manufacturing | 3,157 out of 5,765 | 45th |
Major group Chemicals And Allied Products | 1,178 out of 2,128 | 45th |
Industry group Drugs | 989 out of 1,817 | 46th |
Industry Pharmaceutical Preparations | 768 out of 1,391 | 45th |
Source: SEC filing on May 10, 2019.
Ball's colleagues
We found two more compensation records of executives who worked with Kristine Ball at VYNE Therapeutics in 2018.